Clinical and epidemiologic characteristics of 20 patients with multiple sclerosis in Cuiabá - Mato Grosso, Brazil;Características clínicas e epidemiológicas de 20 pacientes portadores de esclerose múltipla acompanhados em Cuiabá - Mato Grosso

Arquivos de Neuro-Psiquiatria

Volumn 64, Issue 3 A, 2006, Pages

  Grzesiuk, Anderson Kuntz ^a,b  

^a Centro de Reabilitação Integral Dom Aquino Corrêa   (Brazil)

^b NONE   (Brazil)

Author keywords

Clinical findings; EDSS; Epidemiology; Multiple sclerosis

Indexed keywords

BETA1A INTERFERON; CYCLOPHOSPHAMIDE; IMMUNOMODULATING AGENT; IMMUNOSUPPRESSIVE AGENT; INTERFERON BETA SERINE; METHOTREXATE; MITOXANTRONE; IMMUNOLOGIC FACTOR;

ADULT; ARTICLE; BRAZIL; CEREBELLUM DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; ETHNIC DIFFERENCE; FEMALE; HUMAN; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; MALE; MULTIPLE SCLEROSIS; PYRAMIDAL SIGN; RACE DIFFERENCE; RETROSPECTIVE STUDY; SEX RATIO; SYMPTOM; VISUAL DISORDER; ETHNIC GROUP; MIDDLE AGED;

ADULT; ETHNIC GROUPS; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; RETROSPECTIVE STUDIES;

EID: 33749508310     PISSN: 0004282X     EISSN: 16784227     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Victor M, Ropper AH. M. Multiple sclerosis and allied demyelinative diseases. In Victor M (ed). Adams and Victor's Principles of Neurology, 7th Edition-International edition, New York: McGraw-Hill,2001:955.
2. Callegaro D. Aspectos epidemiológicos. In Tilbery CP (ed). Esclerose múltipla no Brasil: aspectos clínicos e terapêuticos. São Paulo: Atheneu, 2005:13-15.
3. Callegaro D, Goldbaum M, Morais L, et al. The prevalence of multiple sclerosis in the city of São Paulo, Brazil. Acta Neurol Scand 2001;104:208-213.
4. Lana-Peixoto MA, Frota E, Campos GB, Botelho CM, Aragão AL. The prevalence of multiple sclerosis in Belo Horizonte, Brazil. Multiple Sclerosis 2002;8(Suppl):S38.
5. Rocha FC, Herrera LC, Morales RR. Multiple sclerosis in Botucatu, Brazil: a population study. Multiple Sclerosis 2002;8(Suppl):S41.
6. Costa MF. História de um país inexistente: o Pantanal entre os séculos XVI e XVIII. São Paulo: Editora Estação Liberdade,1999:54-56.
7. Silva NM. História da neurologia em Mato Grosso. In Reimão R (org). História da neurologia no Brasil. São Paulo: Lemos Editorial;1999: 133-138.
8. Blumhardt LD. Dictionary of multiple sclerosis. London: Martin Dunitz, 2004:47-51.
9. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG. Multiple sclerosis. N Engl J Med 2000;343:938-951.
10. Papais-Alvarenga RM, Santos CMM, Abreu JS, et al. Esclerose múltipla: perfil clínico e evolutivo no Rio de Janeiro. Rev Bras Neurol 1995;31:75-87.
11. Oliveira EML, Annes M, Oliveira ASB, Gabbai AA. Esclerose múltipla: estudo clínico de 50 pacientes acompanhados no Ambulatório de Neurologia UNIFESPEPM. Arq Neuropsiquiatr 1999;57:51-55.
12. Ferreira MLB, Machado MI, Vilela ML, et al. Epidemiologia de 118 casos de esclerose múltipla com seguimento de 15 anos no centro de referência do Hospital da Restauração de Pernambuco. Arq Neuropsiquiatr 2004;62:1027-1032.
13. Arruda WO, Scola RH, Teive HAG, Werneck LC. Multiple sclerosis: report on 200 cases from Curitiba, Southern Brazil and comparison with other Brazilian series. Arq Neuropsiquiatr 2001;59:165-170.
14. Lana-Peixoto MA, Lana-Peixoto MI. Is multiple sclerosis in Brazil and Asia alike? Arq Neuropsiquiatr 2000;58:467-470.
15. Fragoso YD, Fiore APP. Description and characteristics of 81 patients attending the reference center for multiple sclerosis of the coastal region of the State of Sao Paulo-Brazil. Arq Neuropsiquiatr 2005;63:741-744.
16. Moreira MA, Felipe E, Mendes MF, Tilbery CP. Esclerose múltipla: estudo descritivo de suas formas clínicas em 302 casos. Arq Neuropsiquiatr 2000;58:460-466.
17. Sá MJ, Sequeira L, Rio ME, Thompson EJ. Oligoclonal IgG bands in the cerebrospinal fluid of Portuguese patients with multiple sclerosis. Arq Neuropsiquiatr 2005;63:375-379.